¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"primary central nervous system lymphoma"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
  • central synapse
    ÁßÃ߽óÀ½º, ÁßÃß¿¬Á¢
  • central tendon
    Á߽ɳÎÈûÁÙ, °ÇÁß½É
  • central trigeminal neuralgia
    ÁßÃß»ïÂ÷½Å°æÅë
  • central vein cannulation
    Áß½ÉÁ¤¸Æ°ü»ðÀÔ(¼ú)
  • central venous catheter
    Áß½ÉÁ¤¸ÆÄ«Å×ÅÍ
  • central venous pressure
    Áß½ÉÁ¤¸Æ¾Ð
  • central venous pressure monitoring
    Áß½ÉÁ¤¸Æ¾Ð°¨½Ã
  • central vision
    Á߽ɽÃ(·Â)
  • central visual acuity
    Á߽ɽ÷Â
  • central zone
    Á߽ɱ¸¿ª
  • delayed primary suture
    Áö¿¬ÀÏÂ÷ºÀÇÕ
  • primary
    ÀÏÂ÷-, ¿ø¹ß-
  • primary action
    ÀÏÂ÷ÀÛ¿ë
  • primary affect hunger
    ÀÏÂ÷Á¤µ¿°¥¸Á, ÀÏÂ÷¾ÖÁ¤°¥¸Á
  • primary aldosteronism
    ¿ø¹ß¾Ëµµ½ºÅ×·ÐÁõ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
  • central venous pressure
    Áß½ÉÁ¤¸Æ¾Ð
  • central venous pressure monitoring
    Áß½ÉÁ¤¸Æ¾Ð°¨½Ã
  • primary action
    ÀÏÂ÷ÀÛ¿ë, ÀÏÂ÷±â´É
  • primary amenorrhea
    ¿ø¹ß¹«¿ù°æ, ÀÏÂ÷¹«¿ù°æ
  • primary amnion
    ¿ø½Ã¾ç¸·, ÀÏÂ÷¾ç¸·
  • primary amyloidosis
    ¿ø¹ß¾Æ¹Ð·ÎÀ̵åÁõ
  • primary aqueous
    ¿ø¹æ¼ö, ÀÏÂ÷¹æ¼ö
  • primary olfactory receiving area
    ÀÏÂ÷Èİ¢¿µ¿ª
  • primary sensory area
    ÀÏÂ÷°¨°¢±¸¿ª
  • primary bronchus
    ÀÏÂ÷±â°üÁö
  • primary membrane bone
    ¼¼¸Á¼¶À¯¸·»À, ÀÏÂ÷¸·»À
  • primary cancer
    ¿ø¹ß¾Ï
  • primary carcinoma
    ¿ø¹ß¾ÏÁ¾
  • primary cardiomyopathy
    ¿ø¹ß½ÉÀå±ÙÀ°º´Áõ
  • primary cement
    ÀÏÂ÷½Ã¸àÆ®Áú
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
  • achromatic system
    ¹«»ö°è.
  • acid-base buffer system
    »ê¿°±â¿ÏÃæ°è
  • adrenal medulla,tumor of chemoreceptor system
    È­Çмö¿ëü°è Á¾¾ç(ûùùÊáôé»ô÷ͧ ðþåË)
  • adrenal system
    ºÎ½Å°è(Üùãìͧ).
  • aerospace life support system
    (Ç×°ø)¿ìÁÖ¿ë »ý¸íÀ¯Áö½Ã½ºÅÛ.
  • affectional system
    Á¤µ¿Ã¼°è
  • alimentary system(tract)
    ¼ÒÈ­±â°è(á¼ûùÐïͧ)
  • anemia expert system
    ºóÇ÷Àü¹®°¡½Ã½ºÅÛ
  • annular phased array system, APAS
    À§»óµ¿±âÀ±»ó¹è¿­½Ã½ºÅÛ
  • archicortical system
    ¿ø½ÃÇÇÁú°è(¡­Í§)
  • array system
    ¹è¿­ ÀåÄ¡ (¹è¿­ ü°è)
  • gamma motoneuron system
    °¨¸¶¿îµ¿°è(¡­ê¡ÔÑͧ).
  • gas disposal system
    °¡½ºÃ³¸®ÀåÄ¡.
  • gastrointestinal system
    À§Àå°è.
  • gastrointestinal system
    À§Àå°è(êÖíóͧ).
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
  • nodular lymphoma
    °áÀý¼º ¸²ÇÁÁ¾(¡­ðþ)
  • non Hodgkin lymphoma
    ºñÈ£ÁöŲ¸²ÇÁÁ¾.
  • non hodgkin lymphoma
    ºñÈ£ÁöŲ¸²ÇÁÁ¾(¡­ðþ)
  • non-Hodgkins lymphoma
    ºñÈ£ÁöŲ¸²ÇÁÁ¾
  • non-hodgkins lymphoma
    ¸û¸ù¸û¸²ÇÁÁ¾(¡­ðþ)
  • small lymphocytic lymphoma
    ¼Ò¸²ÇÁ±¸ ¸²ÇÁÁ¾
  • t cell lymphoma
    T ¼¼Æ÷ ¸²ÇÁÁ¾
  • t-cell leukemia/lymphoma
    T¼¼Æ÷¹éÇ÷º´/¸²ÇÁÁ¾
  • breakdown nervous
    ½Å°æ¼è¾à
  • intrinsic nervous plexus
    º®¼Ó½Å°æ¾ó±â
  • myenteric nervous plexus
    ±ÙÀ°Ãþ½Å°æ¾ó±â
  • nervous asthenopia
    ½Å°æ(¼º)´«ÇÇ·Î
  • nervous axillaris ; axillary nerve
    °Üµå¶û½Å°æ, ¾×¿Í½Å°æ(äýèÀãêÌè).
  • nervous disease
    ½Å°æÁúȯ(~òðü´).
  • nervous disorder =n. disturbance
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
  • Central tendon
    Á߽ɳÎÈûÁÙ
    [¿¾ ¿ë¾î] °ÇÁß½É
  • Central tegmental tract
    Áß½ÉµÚÆÇ·Î
    [¿¾ ¿ë¾î] Áß½ÉÇǰ³·Î
  • Central lacteal
    Á߽ɸ²ÇÁ°ü
    [¿¾ ¿ë¾î] Áß½ÉÀӯİü
  • Central lymph nodes
    Á߽ɸ²ÇÁÀý
    [¿¾ ¿ë¾î] Áß½ÉÀÓÆÄÀý
  • Central heterochromatic part
    Á߽ɹ¶Ä£¿°»öÁúºÎºÐ
    [¿¾ ¿ë¾î] Áß½ÉÀÌ¿°»öÁúºÎ
  • Central microtubule
    Á߽ɹ̼¼°ü
    [¿¾ ¿ë¾î] Á߽ɹ̼Ұü
  • Central part
    Á߽ɺκÐ
    [¿¾ ¿ë¾î] Á߽ɺÎ
  • Central attachment
    Á߽ɺÎÂø
    [¿¾ ¿ë¾î] Á߽ɺÎÂø
  • Central insertion
    Á߽ɺÎÂø
    [¿¾ ¿ë¾î] Á߽ɺÎÂø
  • Central fiber
    Á߽ɼ¶À¯
    [¿¾ ¿ë¾î] Á߽ɼ¶À¯
  • Central lobule
    Á߽ɼҿ±
    [¿¾ ¿ë¾î] ¼Ò³úÁ߽ɼҿ±
  • Ala of central lobule
    Á߽ɼҿ±³¯°³
    [¿¾ ¿ë¾î] Á߽ɼҿ±ÀÍ
  • Central thalamic radiations
    Á߽ɽûóºÎê»ì
    [¿¾ ¿ë¾î] ±Ã½É½Ã»ó¹æ»ç
  • Central thalamic radiations
    Á߽ɽûóºÎê»ì
    [¿¾ ¿ë¾î] Áß½É½Ã»ó¹æ»ç
  • Central gelatinous substance
    Á߽ɾƱ³Áú
    [¿¾ ¿ë¾î] Á߽ɱ³¾çÁú
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
  • open-circuit system
    °³¹æÈ¸·Î(ËÒÛ¯üÞÖØ) ½Ã½ºÅÛ
  • open system
    °³¹æ(ËÒÛ¯) ½Ã½ºÅÛ
  • optical system
    ±¤(ÎÃ) ½Ã½ºÅÛ
  • phosphotransferase system
    Æ÷½ºÆ÷Æ®¶õ½ºÆÛ·¹À̽º ½Ã½ºÅÛ
  • protein-synthesizing system
    ´Ü¹éÁú ÇÕ¼º(Ó±ÛÜòõùêà÷) ½Ã½ºÅÛ
  • repressible system
    ¾ïÁ¦¼º ½Ã½ºÅÛ
  • restriction-modification system
    Á¦ÇÑ ¼ö½Ä(áóãÞ) ½Ã½ºÅÛ
  • reticuloendothelial system
    ¸Á»ó³»ÇÇ(ØÑßÒÒ®ù«) ½Ã½ºÅÛ
  • Rh blood group system
    Rh Ç÷¾×Çü(úìäûúþ) ½Ã½ºÅÛ
  • RS system
    RS ½Ã½ºÅÛ
  • schlieren optical system
    ½¯¸®·» ±¤ÇÐ(ÎÃùÊ)½Ã½ºÅÛ
  • selective system
    ¼±ÅÃ(àÔ÷É) ½Ã½ºÅÛ
  • state of a system
    ½Ã½ºÅÛ »óÅÂ(ßÒ÷¾)
  • system
    ½Ã½ºÅÛ
  • transport system
    ¼ö¼Û(âÃáê)½Ã½ºÅÛ
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 6
PI first meiotic prophase; isoelectric point; pacing impulse; package insert; pancreatic insufficiency;...
MDS Master of Dental Surgery; maternal deprivation syndrome; medical data screening; medical data system...
MPS meconium plug syndrome; medial premotor system; Member of the Pharmaceutical Society; microbial prof...
NTV Nervous Tissue Vaccine; ½Å°æ Á¶Á÷ ¹é½Å
ARNMD Association for Research in Nervous and Mental Diseases
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 6
CMCT Central Motor Conduction Time
CPG Central Pattern Generator
CPM Central Pontine Myelinolysis
CPU Central Processing Unit
CRA Central Retinal Artery
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • central odontogenic fibroma
    °ñ³» Ä¡¼º ¼¶À¯Á¾
    Ä¡À¯µÎ°¡ °úÀ× Áõ½ÄµÈ °Í. ¾î¸°ÀÌ¿Í ÇϾǿ¡ Àß ¹ß°ßµÈ´Ù. ¿ÏÀüÇÑ ¿Ü°úÀû ÀûÃâÀÌ ¿ä±¸µÇ¸ç Àç¹ßÀº Àß ÇÏÁö ¾Ê´Â´Ù.
  • central pain
    ÁßÃßÅë, ÁßÃß¼º ÅëÁõ, ÁßÃß¼º µ¿Åë
    ÁßÃ߽Űæ°èÀÇ ÁÖµÈ º´¼Ò³ª ±â´ÉÀå¾Ö·Î ÀÎÇÑ ÅëÁõ.
  • central pain phenomenon
    ÁßÃß¼º µ¿Åë Çö»ó
  • central pain transmission cell
    ÁßÃß¼º ÅëÁõ Àü´Þ ¼¼Æ÷, ÁßÃß µ¿Åë Àü´Þ ¼¼Æ÷
  • central pain transmission pathway
    ÁßÃß¼º ÅëÁõ Àü´Þ °æ·Î, ÁßÃß µ¿ÅëÀü´Þ °æ·Î
  • central pathway
    ÁßÃß¼º °æ·Î, ÁßÃß °æ·Î
  • central point artifact
    Áß½ÉÁ¡ Àΰø¹°
  • central position
    Á߸³Àû À§Ä¡
  • central pulse
    Á᫐ ¸Æ¹Ú
  • central red pit
    Á߽ɼº Àû»ö ¼Ò¿Í
  • central renal echo complex
    ½Å Á᫐ ¿¡ÄÚ º¹ÇÕü
  • central retinal artery
    ¸Á¸· Á᫐ µ¿¸Æ
  • central retinal vein
    ¸Á¸· Á᫐ Á¤¸Æ
  • central ridge
    Áß¾Ó ´É¼±
  • central sequestrum
    Á᫐ ºÎ°ñ
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 6
large cell lymphoma <oncology, tumour> Highly malignant group of tumours arising from transformed lymphocytes or myeloid precursors. Cell of origin often obscure.
(18 Nov 1997)
Lennert's lymphoma <tumour> Malignant lymphoma with a high proportion of diffusely scattered epithelioid cells, tonsillar involvement, and an unpredictable course.
Synonym: Lennert's lesion.
(05 Mar 2000)
lymphoblastic lymphoma <tumour> A diffuse lymphoma in children, with supradiaphragmatic distribution and T lymphocytes having convoluted nuclei; many patients develop acute lymphoblastic leukaemia.
(05 Mar 2000)
lymphocytic lymphoma <oncology, tumour> A cancer of lymphatic tissues, the tumour cells are mostly abnormal lymphocytes.
(13 Nov 1997)
lymphoma <oncology, tumour> Malignant tumour of lymphoblasts derived from B lymphocytes. most commonly affects children in tropical Africa: both Epstein Barr virus and immunosuppression due to malarial infection are involved.
(18 Nov 1997)
lymphoma, aids-related B-cell lymphoid tumours that occur in association with aids. Patients often present with an advanced stage of disease and highly malignant subtypes including burkitt lymphoma, immunoblastic large-cell lymphoma, small non-cleaved-cell lymphoma and diffuse large-cell lymphoma. The tumours are often disseminated in unusual extranodal sites and chromosomal abnormalities are frequently present. It is likely that polyclonal B-cell lymphoproliferation in aids is a complex result of ebv infection, HIV antigenic stimulation, and T-cell-dependent HIV activation.
(12 Dec 1998)
lymphoma, B-cell A group of heterogeneous lymphoid tumours generally expressing one or more B-cell antigens or representing malignant transformations of B-lymphocytes.
(12 Dec 1998)
lymphoma, diffuse Malignant lymphoma in which neoplastic cells diffusely infiltrate the entire lymph node without any definite organised pattern. Patients whose lymphomas present a diffuse pattern generally have a more unfavorable survival outlook than those presenting with a follicular or nodular pattern.
(12 Dec 1998)
lymphoma, follicular Malignant lymphoma in which the lymphomatous cells are clustered into identifiable nodules within the lymph nodes. The nodules resemble to some extent the germinal centres of lymph node follicles and most likely represent neoplastic proliferation of lymph node-derived follicular centre B-lymphocytes. This class of lymphoma usually occurs in older persons, is commonly multinodal, and possibly extranodal. Patients whose lymphomas present a follicular or nodular pattern generally have a more indolent course than those presenting with a diffuse pattern.
(12 Dec 1998)
lymphoma, high-grade One of the three major prognostic groupings for non-hodgkin lymphomas as proposed in the working formulation of the non-hodgkin's lymphoma pathologic classification project sponsored by the national cancer institute (1981). Lymphomas falling within this group have a relatively unfavorable survival potential.
(12 Dec 1998)
lymphoma, intermediate-grade One of the three major prognostic groupings for non-hodgkin lymphomas as proposed in the working formulation of the non-hodgkin's lymphoma pathologic classification project sponsored by the national cancer institute (1981). Lymphomas falling within this group have an intermediate survival potential.
(12 Dec 1998)
lymphoma, large-cell A form of malignant lymphoma in which the malignant cells resemble histiocytes morphologically but are presently considered to be derived from lymphoid elements. These cells are irregular in shape with relatively abundant, frequently acidophilic cytoplasm. Large-cell lymphoma can occur in both nodular (follicular) and diffuse forms, with the latter being more frequently seen.
(12 Dec 1998)
lymphoma, large-cell, diffuse Malignant lymphoma composed of large cells which may be both cleaved and noncleaved. The pattern is predominantly diffuse. most of these lymphomas represent the malignant counterpart of B-lymphocytes at midstage in the process of differentiation.
(12 Dec 1998)
lymphoma, large-cell, follicular Malignant lymphoma in which the majority of neoplastic cells within the follicles are large cleaved or noncleaved cells. The degree to which the follicular centre cells retain their ability to form follicles varies with the state of B-cell transformation.
(12 Dec 1998)
lymphoma, large-cell, immunoblastic Malignant lymphoma characterised by the presence of immunoblasts with uniformly round-to-oval nuclei, one or more prominent nucleoli, and abundant cytoplasm. This class may be subdivided into plasmacytoid and clear-cell types based on cytoplasmic characteristics. A third category, pleomorphous, may be analogous to some of the peripheral T-cell lymphomas (lymphoma, T-cell, peripheral) recorded in both the united states and japan.
(12 Dec 1998)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
  • Harvard system
    ÇϹöµå ½Ã½ºÅÛ(Çмú¼­,ÀâÁöÀÇ Âü°í ¹®Çå Ç¥½Ã¹ýÀÇ Çϳª)
  • Information Network System
    °íµµ Á¤º¸ Åë½Å ½Ã½ºÅÛ
  • Montessori method(system)
    (ÀÌÅ»¸®¾ÆÀÇ ¿©¼º ±³À°°¡ À̸§¿¡¼­) ¸óÅ×¼Ò¸®½Ä ±³À°¹ý(¾Æµ¿ÀÇ ÀÚÁÖ¼ºÀÇ ½ÅÀåÀ» Áß½ÃÇÑ ±³À°¹ý) m`
  • PA system
    =PUBLICADDRESS SYSTEM
  • Ptolemaic system
    õµ¿¼³
  • ascent propulsion system
    ¿ìÁÖ Á¤°ÅÀå ±Íȯ¿ë ·ÎÄÏ ¿£Áø
  • barter system
    ¹ÙÅÍÁ¦
  • call connect system
    ÀüÈ­ Á¢¼Ó±â(¿Ü¼±.³»¼± ÀüÈ­¿ÍÀÇ)
  • case system
    ÆÇ·Ê Áß½ÉÀÇ ±³À°¹ý 1
  • centerofmass system
    Á߽ɰè(°èÀÇ Áß½ÉÀÇ ¿îµ¿·®ÀÌ ¿µÀÌ µÇµµ·Ï ÃëÇÑ ÁÂÇ¥°è)
  • chit system
    ÀüÇ¥ ÁöºÒÁ¦
  • circulatory system
    ¼øÈ¯°è(Ç÷¾×À̳ª ¸²ÇÁ¾×ÀÌ È帣°Ô ÇÏ´Â)
  • closed ecological system
    »ýÅÂÇÐÀû Æó¼â°è
  • cold type system
    Äݵå ŸÀÌÇÁ ½Ã½ºÅÛ(³³È°ÀÚ³ª ¿­À» »ç¿ëÇÏÁö ¾Ê°í Çʸ§À» ÁÖü·ÎÇÑ »ç½ÄÈ­¿¡ ÀÇÇÑ Àμ⠰øÁ¤
  • container system
    ÄÁÅ×ÀÌ³Ê ¼ö¼Û¹æ½Ä
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 6
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 6
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 6
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 6
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 6
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 6
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 6
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 6
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 6
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 6
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 6
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 6
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 6
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 6
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 6
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 6
ÅëÇÕ°Ë»ö ¿Ï·á